Skip to main content

Latest Articles

Latest Articles

Showing 9 / 939 GLP-1 Medications articles

Survey: 3M Canadians on GLP-1 Drugs Like Ozempic, Reshaping Eating and Spending
GLP-1 Medications

Survey: 3M Canadians on GLP-1 Drugs Like Ozempic, Reshaping Eating and Spending

A new Leger Healthcare survey estimates that around three million Canadian adults are currently using GLP-1 medications such as Ozempic or Mounjaro. These drugs are not only curbing appetite and cravings but also transforming daily spending habits, from less restaurant takeout to more fresh produce and gym memberships. Weight loss tops the reasons, but barriers like cost keep millions from starting.

Shotlee··5 min read
Beyond Weight Loss: Ozempic Linked to Migraine Reduction, Study
GLP-1 Medications

Beyond Weight Loss: Ozempic Linked to Migraine Reduction, Study

GLP-1 receptor agonists like Ozempic, used for diabetes and weight loss, may offer relief for chronic migraine sufferers by cutting emergency department visits and medication needs. A new study compares them to topiramate, revealing promising associations in stabilizing migraine burden. Presented at the American Academy of Neurology's 2026 meeting, these findings highlight unexpected benefits beyond weight loss.

Shotlee··5 min read